Security record · archived quarter
SANA
Sana Biotechnology, Inc. · Healthcare · Biotechnology
10Tracked holders
—Δ holders
23.15MShares held
$126.39MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +4 | 119.01M | $415.23M | +9 | −5 |
| Q1 2026 | 84 | -3 | 118.01M | $339.95M | +3 | −6 |
| Q4 2025 | 87 | +2 | 116.35M | $473.54M | +2 | — |
| Q3 2025 | 15 | -2 | 97.26M | $345.27M | — | −2 |
| Q2 2025 | 14 | 0 | 77.71M | $212.16M | +2 | −2 |
| Q1 2025 | 11 | -1 | 31.65M | $53.17M | +1 | −2 |
| Q4 2024 | 12 | -1 | 32.20M | $52.48M | +1 | −2 |
| Q3 2024 | 12 | +2 | 22.88M | $95.19M | +2 | — |
| Q2 2024 | 10 | — | 23.15M | $126.39M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 10.57M | — | $57.72M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 2 | Capital World Investors ✦ | 5.45M | — | $29.75M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 3.12M | — | $17.03M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Geode Capital Management ✦ (passive) | 2.89M | — | $15.78M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 5 | Two Sigma Investments ✦ | 413.51K | — | $2.26M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Norges Bank ✦ (passive) | 249.62K | — | $1.36M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Marshall Wace ✦ | 187.71K | — | $1.02M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 158.05K | — | $862,942 | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 59.38K | — | $324,188 | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 49.90K | — | $272,454 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 199 holders, 163.30M shares, $468.43M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Aug 14
SC 13G/A — ARCH Venture Fund IX, L.P.
May 21
SC 13G — RA CAPITAL MANAGEMENT, L.P.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API